PRAXAIR INC 4
4 · PRAXAIR INC · Filed Feb 26, 2014
Insider Transaction Report
Form 4
Breedlove James T
Senior VP, Gen. Counsel & Sec.
Transactions
- Award
Stock Option (right to buy)
2014-02-25+31,090→ 31,090 totalExercise: $128.80From: 2015-02-25Exp: 2024-02-25→ Common Stock (31,090 underlying)
Holdings
- 4,120
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (4,120 underlying) - 37,930
Stock Option (right to buy)
Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (37,930 underlying) - 33,614
Common Stock
- 34,960
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (34,960 underlying) - 29,755
Stock Option (right to buy)
Exercise: $110.58From: 2014-02-26Exp: 2023-02-26→ Common Stock (29,755 underlying) - 5,237.424(indirect: By 401(k))
Common Stock
- 39,300
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (39,300 underlying) - 36,095
Stock Option (right to buy)
Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (36,095 underlying) - 1,259.54
Deferred Stock
Exercise: $0.00→ Common Stock (1,259.54 underlying)
Footnotes (6)
- [F1]This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
- [F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- [F3]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- [F4]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
- [F5]Conversion to Praxair Common Stock is on a 1-for-1 basis.
- [F6]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.